Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1983-1-7
|
pubmed:abstractText |
Twenty-six patients with severe short-distance claudication underwent a 24-week, randomized, double-blind, parallel-group evaluation of the efficacy of pentoxifylline in the treatment of intermittent claudication. The primary variables analyzed were the initial and absolute claudication distances as determined by standardized treadmill walking. A statistically significant improvement in both parameters was present in the pentoxifylline-treated patients. Nausea was the only drug side effect noted.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0039-6060
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
966-71
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7147192-Double-Blind Method,
pubmed-meshheading:7147192-Drug Evaluation,
pubmed-meshheading:7147192-Erythrocytes,
pubmed-meshheading:7147192-Female,
pubmed-meshheading:7147192-Humans,
pubmed-meshheading:7147192-Intermittent Claudication,
pubmed-meshheading:7147192-Male,
pubmed-meshheading:7147192-Middle Aged,
pubmed-meshheading:7147192-Pentoxifylline,
pubmed-meshheading:7147192-Random Allocation,
pubmed-meshheading:7147192-Theobromine
|
pubmed:year |
1982
|
pubmed:articleTitle |
Pharmacologic treatment of intermittent claudication.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|